date:May 11, 2012
ents
The FDA's view - that synthetic botanical constituents, even if they are chemically identical to their natural counterparts, are not dietary ingredients - is one of the most controversial assertions in its 2011 draft guidance on NDIs.
Indeed, while the Council for Responsible Nutrition (CRN)believes a constructive solution might be found to several key sticking points in the guidance, it willnotbudge on the synthetic botanicals issue, CEO Steve Mister told us in February.
He said:We are